Pfizer’s 6.58% yield contrasts with Merck’s 2.74%, as KEYTRUDA drives 12% revenue growth amid biosimilar risks. Pfizer reported a 6.58% dividend yield for 2025, distributing $9.8 billion at $1.72 per share, supported by $3.22 adjusted EPS. Non-COVID growth surged, with Abr
The Healthcare Bridge Strategy a 62 Year Old Couple Used to Cover Five Years to Medicare on $42,000 a Year Quick Read - Keeping MAGI below $80,160 (400% of FPL) is critical because exceeding it by even $1 eliminates ACA subsidies entirely for a retiring couple. - Spending Roth...
Seeing your stocks appreciate is a great feeling because you can see you're making money, even if it's on paper for the time being. Making money regardless of how a stock price moves can be even better because you're not reliant on the sporadic nature of the market
Pivotal bioVenture Partners Investment Advisor increased its position in Trevi Therapeutics (NASDAQ:TRVI) during the first quarter, acquiring 296,944 shares in an estimated $3.32 million trade based on average quarterly pricing, according to a May 14, 2026, SEC filing. Wha
The ARK Space & Defense Innovation ETF (NYSEMKT:ARKX) offers actively managed exposure to disruptive space technologies, while the State Street SPDR S&P Aerospace & Defense ETF (NYSEMKT:XAR) provides low-cost, indexed-based access to established aerospace and defense companies.</
Seeking Alpha analyst Danil Sereda is turning bullish on PayPal (PYPL), citing excessive pessimism and attractive valuations, while Bay Area Ideas has upgraded JetBlue (JBLU) from Sell to Hold as bankruptcy concerns fade. On the downside, James Foord is Newsletters for Eve
Eli Lilly signed a collaboration and licensing agreement with Boston-based Ascidian Therapeutics on Wednesday to research and develop treatments for inherited kidney diseases, with Ascidian eligible to receive up to $1.9 billion under the deal. As part of the agreement, As
Alphabet’s (GOOG, GOOGL) planned $80 billion stock sale puts a new price tag on the AI race: Even Google’s cash machine is tapping Wall Street to keep up. Alphabet stock fell 3.9% Monday, its worst day in two months, as Wall Street digested what the deal says about the ris
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly Top 5 Upgrades: - Morgan Stanley upgraded Yum! Brands (YUM) to Overweight from Equal W
Impax Asset Management, an investment management firm based in London, specializing in sustainable investing, released its first-quarter 2026 investor letter for its “Impax Global Environmental Markets Fund”. A copy of the letter is available to download here The Fu
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.